Follow-up for adults previously treated in NCI surgery studies
Part of Cancer, Skin clinical trials.
This study asks people age 18+ who were previously treated on certain NCI Surgery Branch (NCI-SB) studies to come back for follow-up. It helps researchers understand how patients do over time after those earlier treatments, including some gene therapy studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Have previously received treatment on an NCI Surgery Branch study
- Be willing and able to sign an informed consent form (or have a legal representative sign, if needed)
- If in the consent group for self-signing, you can understand and provide your own consent
- If you can become pregnant, you must not be pregnant (or plan to become pregnant) for this group
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a screening evaluation to see if you might be eligible for cancer treatment research studies at the National Cancer Institute's Surgery Branch. Doctors will review your medical history, imaging, and test results to determine which clinical trials might be right for you.
This study is a follow-up check for people who were previously enrolled in certain NCI gene therapy treatment studies. It helps the research team monitor long-term effects and outcomes after treatment.
This is a follow-up study for adults who previously received certain viral vaccines that carry genes (such as vaccinia or fowlpox) through NCI trials or partner sites. The goal is to store and use your leftover samples for future research that may help doctors understand these treatments better.
This is a follow-up study for people age 18 or older who previously took part in a CAR T-cell gene therapy trial. It helps researchers check your health over time after that treatment and supports long-term safety and outcomes tracking.
This study looks at how different treatments work for people with advanced brain or spinal cord tumors that have come back. It helps doctors learn more about these tumors and how to better treat them.
This study helps collect information and provide certain clinical care and interventions for people who come to the National Cancer Institute (NCI) Clinical Center (CCR). It may be a fit if you need NCI-level evaluation or support because your condition is complex, or if you’re involved as a cellular therapy donor or certain family members needing genetic testing.
Hear when a new Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.